Suvoda Sets a New Benchmark for Clinical Trial Patient and Site Experiences

Suvoda and the Transformation of Clinical Trials

In the ever-evolving landscape of clinical trials, Suvoda has established itself as a pioneer by introducing transformative solutions aimed at simplifying the clinical trial experience for both patients and sites. The innovative technology company made headlines with a significant shift in 2025, merging with Greenphire, which has allowed Suvoda to consolidate its strengths and address ongoing operational challenges faced in clinical trials.

Unifying Technologies for a Seamless Experience

Jagath Wanninayake, CEO of Suvoda, highlighted the pivotal nature of this merger, noting that it has positioned the company to better respond to the needs of clinical trial sites and patients. This consolidation reflects a commitment to innovation, streamlining processes, and enhancing the overall clinical trial journey for everyone involved. As clinical trials become increasingly complex, Suvoda's unified approach aims to lessen this complexity for both trial sites and participants.

A Game-Changer for Patient Engagement

One of the standout developments of the past year has been the launch of Suvoda’s patient application. This platform is designed to enhance patient engagement by providing an intuitive interface that patients can easily navigate on their own devices. By integrating essential features like electronic clinical outcome assessments (eCOA), patient payments, visit scheduling, and reminders into one unified application, patients can manage their involvement in trials more effectively. This not only improves the patient experience but also alleviates the administrative burdens that often plague busy clinical sites.

Leveraging Artificial Intelligence for Efficiency

In addition to the patient application, Suvoda has introduced 'Sofia', an AI assistant designed to streamline access to critical information for study teams. Currently integrated within Suvoda IRT, Sofia allows users to quickly obtain answers to their queries, significantly reducing the time spent navigating through multiple information layers. This innovation not only simplifies the decision-making process but also maintains high standards of data security and study integrity, ensuring that operational efficacy does not come at the cost of compliance.

Recognition and Forward Momentum

The innovative strategies and technologies employed by Suvoda have garnered multiple accolades throughout 2025, including a new patent for their platform architecture, bringing their total to five. The company has also been recognized as a leader in the Everest Group's RTSM PEAK Matrix® evaluation. With continuous improvements in transparency, data quality, and user-friendliness across its product portfolio, Suvoda demonstrates its dedication to practical innovations necessary for real-world trial executions.

Anticipating Future Growth

As we look towards 2026, Suvoda is poised for continuous growth. With an increasing demand from pharmaceutical sponsors and contract research organizations for unified platforms that simplify trial complexities while providing exceptional patient experiences, Suvoda’s unified technology is set to change how clinical trials are conducted.

Jagath Wanninayake reflects on the journey of last year, highlighting the unification of technologies, personnel, and mission as the cornerstone of Suvoda’s vision for the future: "We are ready to deliver even more value in 2026 and beyond, assisting sponsors and sites in meeting their clinical trial needs effectively while ensuring ease of participation for patients."

About Suvoda

Suvoda is a global clinical trial technology company offering a leading real-time software platform that enables sponsors and contract research organizations to make informed decisions, while supporting sites and patients in navigating their participation confidently. With interconnected, action-oriented software solutions and top-tier services, Suvoda ensures that life-changing studies continue to progress, even during critical moments. Headquartered near Philadelphia, with additional offices in Portland (Oregon), Barcelona (Spain), Bucharest and Iasi (Romania), and Tokyo (Japan), Suvoda maintains customer satisfaction rates consistently above industry averages, underscoring its commitment to quality within over 2,000 trials across 95 countries. Following its merger with Greenphire, a leading provider of clinical trial financial management tools and patient support services, Suvoda is positioned for transformative impact in the realm of clinical trials.

For more information, please visit suvoda.com and follow Suvoda on LinkedIn.